2Georgiadis D, Berger A, Kowatschev E, et al. Predictive value of S100- beta and neuron- specificenolase serum levels for adverse neurologic outcome after cardiac surgery [J]. J Thorac Cardiovasc Surg, 2000, 119(1): 138-147.
3Shaaban AM, Haumer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery [J].Br J Anaesth, 2000,85(2) : 287-298.
4Westaby S. Johnson P, Parry AJ, et al. Setamt S100 protein: a potential marker for cerebral events during cardiopulmonary bypass [J]. Ann Throac Surg, 1996, 61(1):88-91.
5Rasmussen LS, Christiansen M, Eliasen K, et al. Biochemical markers for brain damage after cardiac surgery: time profile and correlation with cognitive dysfunction [ J ]. Acta Anaesthesiol Scand, 2002,46(4) : 547 -551.
6Honen J, Salmenpera M. Braininjury after adult cardiac surgery [ J ]. Acta Anaesthesiol Scand, 2004,48(1) : 4-19.
7Tang JF,Chen PL,Tang EJ,et al.Dexmedetomidine controls agita-tion and facilitates reliable,serial neurological examinations in a non-intubated patient with traumatic brain injury[].Neurocrit Care.2011
8Farsak B,Gunaydin S,Yorgancioglu C, et al.Elevated Levels of S2 100beta correlate with neur ocognitive outcome after cardiac surgery[].J Cardiovasc Surg (Tori no).2003
9Mimuro S,Katoh T,Suzuki A,et al.Deterioration of myocardialinjury due to dexmedetomidine administration after myocardial is-chaemia[].Resuscitation.2010
